Petcare Experts

FOUNDER & MANAGING PARTNER

DENVER

Economist, investor and entrepreneur at the intersection of consumer, healthcare & impact.

Former CEO, Defender Bio. Mars, Koch, UC Berkeley, University of Cambridge, George Mason University & Appalachian State University alum. Member of Consumer Analyst Group of New York.

Helped transform Mars into the global market leader in Petcare ($33B/Sales | $100B EV > $45B/Sales | $180B EV) and backed the world’s first early disease prediction AI for pets, ANTECH’s RenalTech.

Husband to Tziporah, dad to 4 humans and one Colorado Mountain Dog (Zoe).

FOUNDER & GENERAL PARTNER

FORT COLLINS

Veterinarian, toxicologist & serial entrepreneur with two decades of experience and multiple successful exits.

VP of BD @ VetSource (exit to Mars). Former Co-Founder & CEO, Lacuna Diagnostics (AI-powered veterinary diagnostic service; exit to Heska/Mars). Colorado State University DVM / MBA / MS alum.

Mars’ Leap Venture Studio alum & Nestle Purina’s Petcare Innovation Prize mentor.

Husband to Alyssa and dad to Vezina, a 2 year old mixed breed puppy.

FOUNDER, VENTURE PARTNER & HEAD OF SAC

DENVER

Veterinarian, biologist, serial entrepreneur and investor with successful exits.

EVP OF R&D, Embark Veterinary. Former CEO, Vidium Animal Health (exit to Anivive). Former CEO PetSmart Charities & Morris Animal Foundation.

Advisor @ Gallant, MyPetGo & the Veterinary Angel Network (VANE). Former head of BD @ Pfizer Animal Health / Zoetis & Colorado State University DVM/PhD alum.

Husband to Claudia, dad to two humans & two golden retrievers (Breckenridge & Bridger).

PRINCIPAL & VENTURE PARTNER

MIAMI / SAN FRANCISCO

Biotech, Animal Health & Life Sciences operator, investor and advisor .

CFO @ Galatea Bio. Led $200M+ in funding & $500M+ in strategic transactions & partnerships for high-growth startups.

Former Co-Founder & CFO @ PetDx and Biotech / Life Sciences Investor @ Stepstone Group & NuFund Venture Group. Wharton EMBA candidate.

VENTURE PARTNER & STRATEGIC ADVISOR

DENVER

Generalist investor and operator with broad expertise in SaaS, MedTech, Healthcare, Chemicals & Life Sciences venture capital & private equity.

Partner @ Cimbal Capital Group. Led >$800M in growth stage venture capital investments as Senior Managing Director of Koch Disruptive Technologies.

Former Executive, Growth Investor & Operator @ Koch Disruptive Technologies, Koch Equity Development & Koch Industries.

Former Board Director @ MedTech/Dx portfolio companies Insightec, Sense Bio, VALO, SHINE & VAYYAR.

VENTURE PARTNER

TEL AVIV

Eli Hasson was the Founding Partner of PHIL Ventures (Pet Health Innovation Labs) – the early-stage investments arm of Australia’s PETstock group.

Based in Tel Aviv, Eli has over 25 years’ experience in the Israeli tech sector – with deep knowledge in business strategy and multi-national operations. He was involved in multiple disruptive digital health ventures and led several technology mega-projects. Eli co-founded Quantum Discoveries – an industry-disrupting mineral exploration company that develops and deploys innovative technologies, operating in Chile and US.

Besides his passion for tech & innovation, Eli is an avid jazz musician and improviser.

VENTURE PARTNER & SCIENTIFIC ADVISOR

SEATTLE

Entrepreneur & advisor at the intersection of veterinary medicine and artificial intelligence.

Research Fellow @ UW Medicine. Former Founder, VetPronto (YC). Love That Pet, Covetrus, Trupanion, & Microsoft alum.

President Elect, Association for Veterinary Informatics. University of Melbourne PhD (Epidemiology & Natural Language Processing), Washington State University DVM.

VENTURE PARTNER & SCIENTIFIC ADVISOR

STILLWATER

Veterinarian entrepreneur, pathologist, professor and scientific advisor. Expert in the intersection of veterinary diagnostics and AI.

Former Chief Medical Officer, Vidium Animal Health (exit to Anivive). Co-Founder, VetDermPath Atlas.

Adjunct Assistant Professor at the Oklahoma State University Center for Veterinary Health. Adjunct Faculty Member at Translational Genomics Institute (TGen). Advisor @ Lynx AI.

Oklahoma State University DVM alum. Diplomate of American College of Veterinary Pathologists (ACVP).

VENTURE PARTNER & SCIENTIFIC ADVISOR

PHOENIX

Founder, Chief Scientist and Cell Biologist. Expert at the intersection of computational biology, oncology, and biotechnology.

Former Co-Founder & Chief Scientist @ Vidium Animal Health (exit to Anivive).

Assistant Professor, Integrated Cancer Genomics Division @ TGen.

Postdoctoral Fellow and Graduate Student at Johns Hopkins School of Medicine where he trained with founders of the field of cancer precision medicine, including Drs. Vogelstein, Papadopoulos, and Kinzler.

Dr. Hendricks has a PhD in Cellular and Molecular Medicine from The Johns Hopkins University School of Medicine, a BS from Arizona State University, and a BA from Grand Canyon University.

SCIENTIFIC ADVISOR

FORT COLLINS

Zoologist, entrepreneur, investor and technical advisor at the intersection of life sciences, biotech and climate tech.

Led >$4B in investments in life sciences and biotechnology spanning government and industry.

CEO @ Photon Pharma (cell therapies for solid tumor cancers), Interim CTO @ WY-CO Engine & an advisor for The March Group, Cedar Street Group & Innosphere Ventures.

Former VP Research, Colorado State University, where he secured Zoetis’ ZINC incubator collaboration in Infectious Disease.

Dr. Rudolph is the former Chief of Biological Sciences & Technology @ DARPA. Defense Threat Reduction Agency & Naval Research Laboratory alum.

Former Founder & CEO @ Adlyfe (Protein Diagnostics). Chair @ Cellphire Tx (Stabilized Cell Therapeutics).

>100 technical publications, three books, and has a number of issued patents from his work.

Dr. Rudolph has a doctorate degree in Zoology from the University of California at Davis and an MBA from George Washington University.